Lilly Buys Three Vaccine Firms in $3.8B Deal
June 1, 2026
Eli Lilly agreed to acquire Curevo, LimmaTech and Vaccine Company in deals worth up to $3.8B to expand its infectious disease pipeline.
June 1, 2026
Eli Lilly agreed to acquire Curevo, LimmaTech and Vaccine Company in deals worth up to $3.8B to expand its infectious disease pipeline.